Home > Income Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹66 Cr₹61 Cr₹58 Cr₹43 Cr₹38 Cr

What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?

The latest Consolidated Net Profit ratio of WINDLAS BIOTECH is ₹66 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹66 Cr
Mar2025₹61 Cr
Mar2024₹58 Cr
Mar2023₹43 Cr
Mar2022₹38 Cr

How is Consolidated Net Profit of WINDLAS BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹66 Cr
8.95
Mar2025 ₹61 Cr
4.82
Mar2024 ₹58 Cr
36.51
Mar2023 ₹43 Cr
11.91
Mar2022 ₹38 Cr -

Compare Consolidated Net Profit of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,044.7 Cr -8.4% -14.1% 8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-8.4%

-14.1%

8.4%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses